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Poor delivery and low bioavailability of therapeutic mole-
cules are the two main obstacles in the drug development
process. The plasma membrane is selectively permeable
and remains a major barrier for most of the therapeutic
molecules. In order to overcome this barrier, a number of
delivery systems have been developed over the years [1,2].
Despite the tremendous progress, the existing delivery
methods can result in high toxicity, immunogenicity and
low delivery yield. In the last decade, short peptides
known as cell penetrating peptides (CPPs) or protein
transduction domains (PTDs) have gained much recogni-
tion as an efficient delivery vehicle [3]. CPPs have remark-
able ability to transverse eukaryotic membranes without
significant membrane damage. In addition, CPPs can carry
a variety of cargoes like peptides [4,5], proteins [6], drugs
[7,8], nucleic acids [9,10], siRNAs [11,12], nanoparticles
[13,14], etc. across the cell membrane. Almost everything
can be transported into the cell, once conjugated to CPP
[15]. Thus, CPPs have a great therapeutic potential, es-
pecially in drug delivery. Although first CPP has been dis-
covered 25 years ago, their mechanism of uptake is still
not very clear. However, two routes of internalization
have been proposed that include direct penetration and
endocytic pathway [16].
Since the discovery of first CPP, i.e. Tat (transcription
activator of the human immunodeficiency virus type 1)
peptide, hundreds of CPPs have been discovered so far
with varied length and physicochemical properties [17].
Most of these peptides are short (up to 35 amino acids),
water soluble, partly hydrophobic, and/or polybasic in
nature with a net positive charge at physiological pH
[18]. In the past, few attempts have been made to
develop computational methods for CPP prediction
[19-22]. In 2008, Hansen et al. developed a method,
which involves a set of z-scales of 87 coded and non-
coded amino acids published by Sandberg and his group
[23]. z-scales require a lot of variables like molecular
weight, molecular orbital calculations, proton NMR
shift, etc. Finally, z-scores obtained are used to predict
the CPPs. This method gave 68% prediction efficiency,
which is very poor to distinguish CPPs from the non-
CPPs. In 2010, Dobchev et al. used quantitative structure-
activity relationship (QSAR) and artificial neural network
(ANN) models to predict CPPs. They achieved maximum
accuracy of 83%. In this method, sequences that are
difficult to predict were excluded. In a recent study,
Sanders et al. (2011) have used support vector machine
(SVM) models to predict CPPs on five different datasets.
They used various biochemical properties to develop SVM
models. One of the major limitations with the previous
methods is that datasets used for training were very small
(< 111) and none of the methods is available in the form
of web service for public use. In addition, most of theprevious methods have used unbalanced datasets, which
presents many problems for machine learning classifiers.
This point has also been highlighted earlier by Sanders
et al. in their study, where they have used both balanced
and unbalanced datasets for machine learning. In balanced
dataset, they achieved 95% accuracy and 75% accuracy
was achieved in unbalanced dataset. This poor perform-
ance of SVM with unbalanced dataset is due to the inher-
ent learning biases of unbalanced dataset, demonstrating
the need for balanced datasets for avoiding biases in ma-
chine learning.
In the present study, we have made a systematic at-
tempt to complement existing methods for predicting
CPPs with high accuracy. We have used large dataset
(708 CPPs) for training, testing and evaluating our
models. The dataset is derived from the CPPsite, which
is the first database of experimentally validated CPPs
[24]. We have used various features like amino acid
composition, dipeptide composition, binary profiles of
pattern, and physicochemical properties as input for de-
veloping SVM models. In addition, we have also identi-
fied various CPP specific motifs, which have been used
to develop a hybrid model. For the first time, a predic-
tion web tool has been developed to assist the scientific
community working in the area of CPPs.
Methods
Main datasets
We have extracted 843 experimentally validated CPPs
from the CPPsite database, which has been developed by
our group [24]. The peptides containing non-natural
amino acids (e.g. selenocysteine) or having D-amino
acids (D-conformation) were removed. Finally, we have
got 708 unique CPPs having natural amino acids. Three
different datasets (CPPsite-1, CPPsite-2 and CPPsite-3)
have been created from these peptides. Since very few
peptides have been experimentally validated as non-
CPPs (negative examples), equal number of peptides
(15–30 amino acids) were generated randomly from
SwissProt proteins, and considered them as non-CPPs.
This strategy for creating negative dataset has already
been used in previous studies [22,25].
First dataset (CPPsite-1) contains 708 CPPs (positive
examples) and 708 non-CPPs (negative examples). In
CPPsite-1, CPPs having wide range of uptake efficiency
(low and high) have been included, thus we have derived
another dataset CPPsite-2 from CPPsite-1. CPPsite-2 con-
tains 187 CPPs having high uptake efficiency and equal
number of non-CPPs. We have created third dataset
(CPPsite-3), which contains 187 CPPs having high uptake
efficacy as positive examples and equal number of CPPs
with low uptake efficiency were taken as negative exam-
ples. The model based on CPPsite-3 dataset can discrimin-
ate between high and low efficient CPPs.
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sist of several CPPs with all possible Ala-scan mutants,
or different truncations. Ideally redundancy in the
datasets should be removed because it affects the per-
formance of prediction method. In past, our group has
removed the redundancy in various prediction methods
[25,26]. But in this study, we have not removed the re-
dundancy in CPP datasets because a single residue can
affect the uptake efficiency of CPPs, and this may also
lead to the loss of information about CPPs. In order to
check the performance of our model on redundant
dataset, we have used some benchmark datasets, which
are redundant.
Benchmark datasets
In order to compare our method with existing methods, we
have extracted datasets from literature that have been used
in previous studies. Sanders et al. (2011) have developed a
method for CPP prediction. In this study, they have used
111 experimentally validated CPPs and equal number of
non-CPPs (generated randomly from the chicken prote-
ome). We have named this dataset Sanders-2011a. Second
dataset from Sanders et al. (2011) named Sanders-2011b,
which contains 111 CPPs and 34 experimentally validated
non-CPPs. We have also generated a third dataset Sanders-
2011c consisting of 111 CPPs, and 111 non-CPPs randomly
sampled from 34 known non-CPPs. Dobchev et al. (2010)
have used 74 CPPs and 24 non-CPPs for developing
method for CPP prediction. These peptides were collected
from the literature. We have used this dataset in this study
and named Dobchev-2010. Similarly, we have created data-
sets Hansen-2008 (containing 66 CPPs & 19 non-CPPs)
[20] and Hallbrink-2005 (containing 53 CPPs & 16 non-
CPPs) from previous studies [19].
Independent dataset
In order to evaluate the performance of our method, we
have created an independent dataset of 99 novel CPPs,
which have not been included in the training, feature se-
lection and parameter optimization of the model. These
peptides have been collected manually from recent re-
search papers and patents.
Cross-validation technique
The validation of any prediction method is very essential
part. In the present study, five-fold cross-validation tech-
nique was used to evaluate the performance of all the
models. Here, sequences are randomly divided into five
sets, of which four sets are used for training and the
remaining fifth set for testing. The process is repeated
five times in such a way that each set is used once for
testing. Final performance is obtained by averaging the
performance of all the five sets. In this study, we have
also used jack-knife cross validation or Leave One OutValidation (LOOV) technique for evaluating perform-
ance of our models. In this technique, one sample is
used for testing and remaining samples for training, this
process is repeated in such a manner that each sample is
used only once for testing.
Support vector machine
We have used a highly successful machine learning classi-
fier known as SVM for building prediction models. There-
fore, we implemented SVMlight Version 6.02 package of
SVM [27] and machine learning was carried out using vari-
ous kernels (e.g. linear, polynomial, radial basis function
and sigmoid tanh), where each input dot is converted
into nonlinear kernel function. Here, we used RBF kernel
of SVM at different parameter; g ∈ [10-4 - 10], c ∈ [1-15],
j ∈ [1-5] for optimizing the SVM performance to get the
best performance. SVM requires a set of fixed length of
input features for training, thus necessitating a strategy for
encapsulating the global information about proteins/
peptides of variable length in a fixed length format. The
fixed length format was obtained from protein/peptide se-
quences of variable length using amino acid composition,
dipeptide composition and binary profile of pattern. After
training, learned model can be used for the prediction of
unknown examples.
Amino acid composition
Peptide information can be encapsulated in a vector of
20 dimensions, using amino acid composition of the
peptide. The amino acid composition is the fraction of
each amino acid type within a peptide. The fractions of
all 20 natural amino acids were calculated by using the
following equation:
Comp ið Þ ¼ Ri
N
 100
Where Comp (i) is the percent composition of amino
acid (i); Ri is number of residues of type i, and N is the
total number of residues in the peptide.
Dipeptide composition
The dipeptide composition provides composition of pair
of residues (e.g. Ala-Ala, Ala-Leu, etc.) present in pep-
tide, and used to transform the variable length of pep-
tides to fixed length feature vectors. It gives a fixed
pattern length of 400 (20 × 20), and encapsulates infor-
mation about the fraction of amino acids as well as their
local order. It is calculated using following equation:
Fraction of Dipeptide ið Þ
¼ Total number of Dipeptide ið Þ
Total number of all possible dipeptides
Where dipeptide (i) is one out of 400 dipeptides.
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Binary profiles were generated for each peptide, where
each amino acid is represented by a vector of dimensions
of 20 (e.g. Ala by 1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0) as
described in supporting information (Additional file 1:
Figure S1). A pattern of window length W was repre-
sented by a vector of dimensions 20 ×W. We have created
binary profile for first 5 and 10 residues from N-terminus,
similarly for last 5 and 10 residues from C-terminus of
peptides in all datasets. The binary profile has been used
in a number of existing methods [28,29].
Physicochemical properties
Physicochemical properties like amphipathicity, hydro-
phobicity, charge, length, etc. have been previously
shown to be useful in the prediction of CPPs [20,22].
We have calculated these properties (amphipathicity,
hydrophobicity, charge, molecular weight, length, iso-
electric point, side chain bulk, steric bulk, net donated
hydrogen bonds, and number of polar and non-polar
residues) of amino acids to develop prediction models
for CPPs. We have taken numerical values of these phys-
icochemical properties from latest version of AA index
database [30].
Sequence logos
The sequence logos were generated using online WebLogo
software [31]. The sequence logo gives the position specific
frequency of amino acids in peptides. Each logo consists
of stacks of symbols, one stack for each position in the
sequence. The overall height of the stack indicates the
sequence conservation at that position, while the height of
symbols within the stack indicates the relative frequency of
each amino acid at that position.
MEME/MAST motifs
We have observed various common patterns/motifs in
CPPs. In order to identify motifs in CPPs, we have used
MEME/MAST program [32]. In the present study,
meme-4.7.0 version was used. We got the number of
motifs in CPPs using MEME, and these motifs have been
used further to scan peptides for the presence of CPP
specific motifs using program MAST. Hits obtained in
the MAST output were used to calculate the efficacy
and coverage of MEME/MAST method. E-value is very
crucial in the MAST output, so we took this into ac-
count and calculated the efficacy of this method at dif-
ferent E-values (10-10-7).
Hybrid approach
In hybrid approach, we have combined SVM output
with motif information obtained by MEME/MAST for
the better and biologically reliable prediction of CPPs. In
this approach, for a query peptide, first SVM model isapplied and it generates an SVM score. In parallel, the
query peptide is searched against the CPP motifs, if any
motif is found in the peptide; its SVM score is increased
by a value of 5, so that in any case, it would be predicted
as positive whatever is the original prediction.
Performance measure
The performance of various models developed in this
study was computed using threshold-dependent as well as
threshold-independent parameters. In threshold dependent
parameters we used sensitivity (Sn), specificity (Sp), overall
accuracy (Ac) and Matthew’s correlation coefficient (MCC)
using following equations.
Sensivity ¼ TP
TP þ FN  100
Specificity ¼ TN
TN þ FP  100
Accuracy ¼ TP þ TN
TP þ FP þ TN þ FN  100
MCC ¼ TP x TNð Þ  FP x FNð Þ
TPþ FPð Þ TPþ FNð Þ TNþ FPð Þ TNþ FNð Þ
Where TP and TN are correctly predicted positive and
negative examples, respectively. Similarly, FP and FN
are wrongly predicted positive and negative examples
respectively.
We created ROC (Receiver Operating Characteristic)
for all of the models in order to evaluate performance of
models using threshold-independent parameters. ROC
plots with area under curve (AUC) were created using
ROCR statistical package available in R [33].
Results
Amino acid composition analysis of CPPs
In order to understand whether certain types of amino
acids are dominated in CPPs, overall percent average
composition of amino acids in CPPs and non-CPPs has
been calculated and compared (Figure 1a). Analysis re-
vealed that Arg, Lys, and Trp were significantly abun-
dant in CPPs, while composition of Pro and Cys were
slightly higher in CPPs than non-CPPs (Figure 1a). Next,
we wanted to know whether certain types of residues are
dominated at N- and C- terminus. To address this, we
have computed percent average residue composition of
both N- and C- termini (spilt amino acid composition).
However, we did not observe significant difference in
split amino acid composition from the overall residue
composition in CPPs (Figure 1b and 1c).
Residues preference in CPPs
We next analyzed whether certain types of residues are
preferred at specific positions in CPPs. To understand
Figure 1 Amino acid composition comparison. Comparison of percent average amino acid composition of (a) whole peptides, (b) N-terminal
residues, and (c) C-terminal residues between CPPs and non-CPPs.
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Figure 2 Sequence logo of first ten residues (N-terminus) of
CPPs. The figure depicts the sequence logo of first ten residues
(N-terminus) of CPPs, where size of residue is proportional to
its propensity.
Table 1 Performance of composition-based SVM method
Dataset Sensitivity Specificity Accuracy MCC ROC
CPPsite-1 89.12 91.81 90.47 0.81 0.96
CPPsite-2 92.51 88.24 90.37 0.81 0.96
CPPsite-3 70.59 67.38 68.98 0.38 0.73
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the termini was examined. It was observed that particular
types of residues are preferred over others in CPPs at N-
and C-terminus. In order to demonstrate residue prefer-
ence at different position of CPPs, sequence logos [31]
were generated. The sequence logos of 10 N-terminal and
C-terminal residues of peptides are shown in Figure 2 and
3 respectively. It is clearly depicted in Figure 2 and 3 that
basic residues (Arg and Lys) are preferred at most of the
positions. However, certain residues like Leu, Ala, Ile, and
Trp (at N-terminus) and Leu, Ser, and Pro (at C-terminus)
are also preferred at various positions in CPPs.
Amino acid composition-based SVM model
It has been shown in the past that amino acid composition
can be used to classify the different classes of peptides and
to develop prediction tools using machine-learning tech-
niques [34,35]. In composition analysis, we have found
that certain types of residues are preferred over the others
in CPPs. Thus, it was possible to discriminate CPPs from
non-CPPs based on amino acid composition. Therefore,
we have developed an SVM model using amino acid com-
position as input feature. The performance of this model
is summarized in Table 1. For CPPsite-1, we have found aFigure 3 Sequence logo of last ten residues (C-terminus) of
CPPs. The figure depicts the sequence logo of last ten residues
(C-terminus) of CPPs, where size of residue is proportional to
its propensity.maximum accuracy of 90.47% with MCC and ROC
values 0.81 and 0.96, respectively. In case of CPPsite-2,
we have achieved maximum accuracy of 90.37% with
MCC and ROC values 0.81 and 0.96, respectively. For
dataset CPPsite-3, we have achieved a maximum accur-
acy of 68.98% with MCC and ROC values 0.38 and 0.73,
respectively. This indicates that performance of this
model on CPPsite-3 dataset (which discriminates high
and low efficient CPPs) is relatively poor.
Dipeptide composition-based SVM model
Since the dipeptide encapsulates the global information of
the amino acid fraction and the local order of amino acids,
it is a better feature as compared to amino acid compos-
ition alone. Dipeptide composition has been used in earl-
ier studies to differentiate two different types of proteins
and peptides [36]. Thus, we have developed an SVM
model based on dipeptide composition. This model
performed more or less similar to composition–based
model. Results are shown in Table 2. In case of CPPsite-1,
we achieved a maximum accuracy of 90.04% with MCC
and ROC values of 0.80 and 0.95, respectively. For
CPPsite-2, maximum accuracy achieved was 92.78% with
MCC and ROC values of 0.86 and 0.97, respectively. For
CPPsite-3, maximum accuracy was 67.11% with MCC and
ROC values of 0.34 and 0.71, respectively.
Binary profile-based SVM model
In preliminary analysis, certain residues (Ala, Pro, Leu, Ile,
Trp, Ser) along with Arg and Lys are also preferred at vari-
ous positions at N- and C-terminus. To incorporate this
position specific information in the model, we have gener-
ated binary profile patterns of peptides. In binary pattern,
a vector of dimension 20 represents a residue, and for n
residues the input vector of dimension is (20 × n). We
have used the following three approaches:
N-terminal approach
In this approach, we have extracted 5 and 10 N-terminus
residues from each peptide in all three datasets, andTable 2 Performance of dipeptide-based SVM method
Dataset Sensitivity Specificity Accuracy MCC ROC
CPPsite-1 88.14 91.95 90.04 0.80 0.95
CPPsite-2 90.91 94.65 92.78 0.86 0.97
CPPsite-3 72.73 61.50 67.11 0.34 0.71
Table 3 Performance of binary profile-based SVM method
Method CPPsite-1 dataset CPPsite-2 dataset CPPsite-3 dataset
Sn Sp AC MCC ROC Sn Sp AC MCC ROC Sn Sp AC MCC ROC
N5 80.08 85.73 82.91 0.66 0.89 86.63 87.17 86.90 0.74 0.90 62.03 65.78 63.90 0.28 0.64
C5 84.60 82.20 83.40 0.67 0.91 91.44 82.35 86.90 0.74 0.95 64.17 67.38 65.78 0.32 0.66
N5-C5 83.19 88.98 86.09 0.72 0.96 91.98 82.35 87.17 0.75 0.95 66.84 66.84 66.84 0.34 0.69
N10 83.95 86.19 85.03 0.70 0.91 89.44 90.34 89.87 0.80 0.95 66.67 63.27 65.05 0.30 0.65
C10 86.55 83.22 84.95 0.70 0.93 87.04 91.10 88.96 0.78 0.95 66.05 61.90 64.08 0.28 0.68
N10-C10 90.60 86.89 88.81 0.78 0.95 93.21 93.84 93.51 0.87 0.96 66.67 64.63 65.70 0.31 0.68
Sn: sensitivity, Sp: specificity, AC: accuracy.
Table 4 Performance of physicochemical properties-based
SVM method
Dataset Sensitivity Specificity Accuracy MCC ROC
CPPsite-1 91.24 90.25 90.75 0.82 0.95
CPPsite-2 91.98 89.84 90.91 0.82 0.95
CPPsite-3 73.80 63.64 68.72 0.32 0.70
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respectively. These profiles were then used to develop
SVM model. Comparisons of performances of binary-
based SVM models are shown in Table 3. Model devel-
oped on CPPsite-2 dataset performed better than
models developed on other two datasets.
C-terminal approach
We have used the same strategy for the C-terminus as
used for the N-terminus. The performance of binary-
based SVM model using 5 and 10 C-terminal residues
was almost similar to N-terminal approach (Table 3).
N + C-terminal approach
In order to check, if using the N- and C-termini of the
peptides together will enhance the accuracy of the
method or not, we developed an N + C-terminus based
approach. In this approach, we have developed two
datasets, named N5-C5 and N10-C10. First 5 residues
from the N-terminal were joined with 5 residues from
C-terminal in N5-C5 dataset. Similarly in N10-C10, first 10
residues from N-terminal were joined with last 10 residues
from C-terminal. The comparative performances of binary-
based SVM model using N +C terminal residues are shown
in Table 3. For CPPsite-1, CPPsite-2 and CPPsite-3 datasets,
maximum accuracy of 88.81%, 93.51% and 66.84% was
achieved respectively. This model performed better in case
of CPPsite-2 dataset, than the models based on above two
approaches.
Physicochemical properties-based SVM model
For each dataset, we have calculated a set of physico-
chemical properties (described in material and methods)
of each peptide, which were previously shown to be use-
ful for prediction of CPPs [20]. SVM model using these
physicochemical properties has been developed. Per-
formance of this model was similar to composition-
based model. Results are summarized in Table 4. For
CPPsite-1, we have achieved maximum accuracy of
90.75% with MCC and ROC values of 0.82 and 0.95, re-
spectively. For CPPsite-2, maximum accuracy of 90.91%
with MCC and ROC values of 0.82 and 0.95 respectively,was achieved. For CPPsite-3, maximum accuracy of
68.72% with MCC and ROC values, of 0.32 and 0.70 re-
spectively, was achieved.
Cross-validation techniques
We have evaluated our models using five-fold cross
validation and LOOCV techniques. As shown in
supporting information (Additional file 1: Tables S1-S4),
performance of models was nearly same when evaluated
using LOOCV or using five-fold cross-validation tech-
nique. Therefore, for the further studies on CPPs pre-
diction, we have used five-fold cross validation only,
because it is less expensive in terms of time and com-
puter usage as compared to the LOOCV.
MEME/MAST motif based method
In the previous studies, motif information has been used
for the prediction of other biological problems e.g. pre-
diction of sub-cellular localization of proteins [37]. We
have observed various motifs in CPP datasets. These
motifs were fished out using MEME software with E-
value of 10. Subsequently, this motif information has
been used for the prediction of CPPs. We have repeated
the motif-based method at different E-values form 10 to
10-7 for each dataset. Results of all the three datasets are
presented in Table 5. Here, it should be noticed that
probability of correct prediction is satisfying, but on the
other hand, percent coverage is not recommendable in
all the three datasets as shown in Table 5.
Hybrid prediction model
As we noticed, that MEME/MAST method has excellent
ability to predict CPPs, but with very little coverage
(Table 5). Therefore, we have developed a hybrid method
Table 5 Performance of MEME/MAST-based SVM method
E-value CPPsite-1 CPPsite-2 CPPsite-3
PCP % Coverage PCP % Coverage PCP % Coverage
10 0.50 81.17 0.48 79.88 0.54 79.88
1 0.50 74.40 0.48 74.71 0.56 74.71
0.1 0.48 63.10 0.50 69.54 0.60 69.54
0.01 0.5 54.97 0.53 62.64 0.63 62.64
1E-02 0.56 50 0.57 56.32 0.64 56.32
1E-04 0.64 45.03 0.62 52.87 0.65 52.87
1E-05 0.74 42.92 0.70 51.14 0.66 51.14
1E-06 0.83 39.46 0.83 48.28 0.66 48.28
1E-07 0.90 36.45 0.88 45.98 0.68 45.98
PCP: Percentage of correct prediction.
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pattern profile-based SVM model in order to take the
advantage of accuracy of MEME/MAST method. Hybrid
model achieved maximum accuracies (at E-value 10) of
92.85%, 97.40% and 78.96% for CPPsite-1, CPPsite-2 and
CPPsite-3 datasets respectively. Results of hybrid ap-
proach are shown in Table 6.
ROC plot
In order to have a threshold-independent evaluation of
our models, we have generated ROC curve for all the
models. ROCR statistical package was used for creating
ROC plots with area under curves (AUC). As shown in
Figure 4, composition-based method performed well
over the other methods. However, when we compared
composition-based method with the hybrid method, hy-
brid method performed well as compared to the
composition-based method at all the E-values (Figure 5).
Comparison with existing methods
In order to validate our method, performance of binary-
based method was evaluated on independent dataset andTable 6 Performance of hybrid method
E-Value CPPsite-1 dataset CPPsite-2 datas
Sn Sp AC MCC ROC Sn Sp
10 91.90 93.88 92.85 0.86 0.97 98.15 96.58
1 91.41 93.88 92.60 0.85 0.97 96.91 96.58
0.1 91.25 93.88 92.51 0.85 0.97 95.68 96.58
0.01 90.76 93.88 92.26 0.85 0.97 95.06 96.58
1E-02 89.63 93.88 91.67 0.83 0.97 94.44 96.58
1E-04 88.65 93.88 91.17 0.83 0.97 94.44 96.58
1E-05 88.17 93.88 90.92 0.82 0.96 94.44 96.58
1E-06 88.01 93.88 92.83 0.82 0.96 94.44 96.58
1E-07 87.52 93.88 90.58 0.81 0.96 94.44 96.58
Sn: sensitivity, Sp: specificity, AC: accuracy.we achieved 81.31% accuracy with 0.63 MCC. In addition,
we developed and evaluated our models on benchmark
datasets. A comparison of previously published predic-
tion methods with our approach is shown in Table 7
and supporting information (Additional file 1: Table
S5). These results clearly demonstrate that hybrid
model is more accurate than previous methods and may
complement the existing methods.
Implementation and designing of CPPs
Currently, no web service is available for the prediction
of CPPs till date. Thus, in order to serve scientific com-
munity, we have implemented our best methods (binary
N10-C10 and hybrid) in a user-friendly web server
‘CellPPD’ with many other useful tools for the users
(Figure 6). CellPPD web server not only provides facility
to predict peptides as CPPs or non-CPPs, but also it of-
fers opportunity to design analogues with better cell
penetrating abilities. The detailed information related
to designing of CPP analogues has been provided in
supporting information (Additional file 2). User may
submit the peptide sequence (no FASTA format re-
quired) in single letter code, and server will generate all
the possible mutants of given peptide with single muta-
tion in each mutant (depicted in red color). For each
mutant peptide, server will give an SVM score and pre-
diction status CPP or non-CPP according to the thresh-
old cut-off chosen by the user. As this server allows
users to select a threshold, we suggest the users to select
higher value if they are interested in high specificity
(high confidence). Therefore, this feature will be very
helpful for user in designing highly effective CPP ana-
logues. In addition, server also calculates important
physicochemical properties in an aesthetic table format
(Figure 6). In the same table, original peptide will also be
displayed and sorting option has been provided, which
can be used to sort the peptide analogues based on de-
sired properties and eventually to select the best peptideet CPPsite-3 dataset
AC MCC ROC Sn Sp AC MCC ROC
97.40 0.95 0.99 80.86 76.87 78.96 0.58 0.86
96.75 0.93 0.99 79.01 76.87 77.99 0.56 0.84
96.10 0.92 0.99 76.54 76.87 76.70 0.53 0.83
95.78 0.92 0.99 74.07 76.87 75.40 0.51 0.81
95.45 0.91 0.98 71.60 76.87 74.11 0.48 0.79
95.45 0.91 0.98 53.09 76.87 64.40 0.31 0.68
95.45 0.91 0.98 53.09 76.87 64.40 0.31 0.68
95.45 0.91 0.98 53.09 76.87 64.40 0.31 0.68
95.45 0.91 0.98 70.59 67.38 68.98 0.38 0.73
Figure 4 The performance of SVM models developed using
composition, dipeptide and physicochemical property profile
on CPPsite-1 dataset (where 1-specificity represents the false
positive rate and value in bracket shows area under curve).












Sanders-2011a 95.94 96.40 98.65 97.75
Sanders-2011b 75.86 82.07 83.45 83.45
Sanders-2011c 88.73 88.74 89.64 90.09
Dobchev-2010 83.16 81.63 81.63 83.33
Hansen-2008 67.44 78.82 83.53 80.00
Hallbrink-2005 77.27 92.75 95.65 97.06
Gautam et al. Journal of Translational Medicine 2013, 11:74 Page 9 of 12
http://www.translational-medicine.com/content/11/1/74analogue. There is a provision to submit and design
multiple peptides at a time. For this, user has to submit
multiple sequences in FASTA format. Another inform-
ative tool is the scanning of protein for the detection of
putative CPPs. Here, user may submit the protein se-
quence, and server will generate overlapping peptides ofFigure 5 The performance of SVM models developed using
composition and hybrid models on CPPsite-1 dataset (where
1-specificity represents the false positive rate and value in
bracket shows area under curve).window length selected by the user, where all the pep-
tides will be clickable. This tool can help users to dig
out a protein sequence for possible CPPs. Graphical rep-
resentation of results is an interesting feature providing
an estimate of total CPPs containing regions in the pro-
tein. Motif scanning is another handy tool for the user
to find CPP motifs in a protein sequence. We have also
provided a list of 120 CPP motifs present in our
dataset of CPPs. In addition, few examples (prediction
test on well-known CPPs and their non-penetrating
non-CPP analogues) have been incorporated in
supporting information (Additional file 2) for accuracy
comparison of our method. CellPPD is freely accessible
at http://crdd.osdd.net/raghava/cellppd.Discussion
Due to huge therapeutic applications of CPPs, especially
in drug delivery, identification of novel and highly effi-
cient CPPs is need of the hour. However, identification
of highly efficient CPPs is a very tedious task for biolo-
gists. One has to scan the whole protein in overlapping
window patterns, and every peptide has to be tested for
the possible cell penetrating activity, which is a very la-
borious and time consuming cycle. A computational
method, which can determine whether a peptide se-
quence can be a CPP or not, would definitely help biolo-
gists for rapid screening of CPPs before synthesis and
thus, accelerate the CPP-based research. The develop-
ment of an in silico method for CPP prediction is very
challenging due to three major reasons; (i) CPPs have lot
of variation in size (5 – 30 amino acids), and machine
learning software need fixed length patterns as input to
develop model, (ii) experimentally proven non-CPPs
(negative dataset) are not reported in literature, which
are very important for developing the in silico method,
and (iii) other major problem in CPP prediction is the
lack of dataset of peptides (CPPs and non-CPPs) tested
in similar experimental conditions (e.g. concentrations,
incubation time, cell lines, type of cargoes, etc.). In most
of the CPP-based research, uptake of peptides has been
Figure 6 Schematic presentation of CellPPD webserver with an example of SVM based prediction results.
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http://www.translational-medicine.com/content/11/1/74tested on different cell lines with different experimental
conditions. It could be possible that few non-penetrating
analogues of previously known CPPs may act as CPP
when evaluated on alternative cell lines or in different
experimental conditions. Sanders et al. have also observed
a similar observation, where a previously known non-CPP
found to have some penetrating properties when tested on
different cell lines (i.e. avian cell line) [22]. Therefore, for
the better and more accurate prediction, larger dataset of
CPPs and non-CPPs tested in number of cell lines with
similar experimental conditions are required. However, in
the past, few attempts have been made to predict CPPs
[19-22], but all these methods used very small dataset and
none of these has provided web service. In the last decade,
a large amount of data on the use of CPPs as delivery
agents has accumulated and this enormous growth of CPP
data motivated us to develop an in silico method on a lar-
ger dataset of 708 experimentally validated CPPs. In order
to develop a robust computational method, which can dis-
criminate CPPs from non-CPPs with higher accuracy, we
have developed SVM models on three datasets (CPPsite-1,
CPPsite-2 and CPPsite-3) using many features like amino
acid composition, dipeptide composition, binary pattern
of profile and CPP motifs.Performances of SVM models developed on dataset
CPPsite-1 and CPPsite-2 were significantly better than
models developed on CPPsite-3 dataset. This is due
the fact that in CPPsite-3, both positive and negative ex-
amples are CPPs; the only difference is that positive ex-
amples consist of CPPs with high uptake efficiency,
while negative examples consist of CPPs with low uptake
efficiency. Since peptides in both the classes are CPPs
and contain similar properties including amino acid
composition (Additional file 1: Figure S2), they are diffi-
cult to discriminate.
SVM models using amino acid and dipeptide com-
position as input features performed reasonably good
and achieved more or less similar accuracy. Recently,
Sanders et al. (2011) published a method, in which they
have used amino acid compositions and 41 other bio-
chemical properties, including amino acid frequency,
length, hydrophobicity, etc. as an input feature to de-
velop SVM model. We have shown that amino acid
composition alone can predict CPP with better accuracy
(Table 7). The dipeptide-based model achieved greater
accuracy (98%) for Sanders-2011a dataset, while the
increase in accuracy (95.94% to 96.40%) for whole amino
acid composition-based model for Sanders-2011a dataset is
Gautam et al. Journal of Translational Medicine 2013, 11:74 Page 11 of 12
http://www.translational-medicine.com/content/11/1/74negligible and could be due to the random sampling of
negative examples. One of the limitations in composition-
based model is that it only computes the overall number of
residues in peptides and loses the amino acid order infor-
mation, which is equally important. It is well known that
the peptide’s function is strongly related to its sequence
order. Evidence suggests that conformation of CPPs plays a
crucial role in membrane interaction and insertion [38]. It
has been shown that CPP with helical conformation can
penetrate membrane more effectively than the peptides
with other conformations [38]. Many amphipathic CPPs
adopt helical conformation in which all the polar residues
grouped at one face and the nonpolar residues to the op-
posite face of the helix. This amphipathic helical distribu-
tion can also be associated to specific amino acids and
with a particular order. In addition, preliminary analysis
(Figures 2 and 3) has also shown that certain residues are
preferred at specific positions in CPPs. Therefore, in order
to include this information, we have developed SVM
models based on binary profile of patterns, which incorpo-
rates information of both composition and amino acid
order. In many previous studies, binary profiles patterns-
based SVM model performed better than composition-
based model [25,26]. In this study also, N10-C10 binary
profile-based SVM model achieved maximum accuracy
(93.51%) in CPPsite-2 dataset.
In addition, we have also developed motif-based
method using MEME/MAST, where MEME is used to
discover motifs and MAST is used to search these mo-
tifs in CPPs. We conducted our study keeping in mind
that the CPPs might share some patterns/motifs. This
approach has been used successfully in the past to differ-
entiate two different classes of peptides [37]. In the
present study also, the model developed on motif-based
approach has predicted CPPs with reasonable accuracy.
Finally, in order to improve performance of the model, a
hybrid model using both binary profile patterns and
motif information was developed. Motif information has
further increased the accuracy of CPP prediction. We
also compared our method with existing methods on
benchmark datasets. The performance of our method
was better than existing methods. Furthermore, in order
to help biologists, we have implemented our best models
in a user-friendly web server CellPPD.Conclusions
There is a rapid growth in the field of CPP research in
response to the demand for novel drug delivery systems.
CellPPD is one such efficient method that can predict
highly efficient CPPs and help to find newer CPP ana-
logues more speedily and conveniently. We hope that es-
tablishment of such method will speed up the pace of
identifying improved and efficacious CPPs in future.Additional files
Additional file 1: Figure S1. Generation of binary profile of pattern.
Figure S2. Percent average amino acid composition of peptides in
CPPsite-2 and CPPsite-3 datasets. Table S1. Performance of composition-
based SVM method. Table S2. Performance of dipeptide-based SVM
method. Table S3. Performance of physicochemical-based SVM method.
Table S4. Performance of binary profile-based SVM method. Table S5.
Performance on benchmark datasets.
Additional file 2: Designing of CPPs and case studies. Describes the
utility of CellPPD webserver in designing better cell penetrating
analogues and explains the accuracy comparison of CellPPD using few
examples (case studies).
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